Personalis (NASDAQ: PSNL) has attracted takeover interest from pharmaceutical giant Merck (NYSE: MRK) and at least two other suitors, according ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE